Main > ONCOLOGY (**) > Leukemia>Myeloid>Chronic>CP Ph+ > TREAT.: > CH. N. Asciminib Tablets

---

CH. N. Asciminib Tablets's subsections
(*) USA Approval Date: 2021. 10.29
Company
RTM
RTM Web-Site
USA Patent Number

CH. N. Asciminib Tablets's products
This section has no products